Literature DB >> 20304922

Post-translational modification of the NKG2D ligand RAET1G leads to cell surface expression of a glycosylphosphatidylinositol-linked isoform.

Maki Ohashi1, Robert A Eagle, John Trowsdale.   

Abstract

NKG2D is an important activating receptor on lymphocytes. In human, it interacts with two groups of ligands: the major histocompatibility complex class I chain-related A/B (MICA/B) family and the UL-16 binding protein (ULBP) family, also known as retinoic acid early transcript (RAET1). MIC proteins are membrane-anchored, but all of the ULBP/RAET1 proteins, except for RAET1E and RAET1G, are glycosylphosphatidylinositol (GPI)-anchored. To address the reason for these differences we studied the association of RAET1G with the membrane. Using epitope-tagged RAET1G protein in conjunction with antibodies to different parts of the molecule and in pulse-chase experiments, we showed that the C terminus of the protein was cleaved soon after protein synthesis. Endoglycosidase H and peptide N-glycosidase treatment and cell surface immunoprecipitation indicated that most of the protein stayed in the endoplasmic reticulum, but some of the cleaved form was modified in the Golgi and transported to the cell surface. We examined the possibility of GPI anchoring of the protein in three ways: (i) Phosphatidylinositol (PI)-specific phospholipase C released the PI-linked form of the protein. (ii) The surface expression pattern of RAET1G decreased in cells defective in GPI anchoring through mutant GPI-amidase. (iii) Site-directed mutagenesis, to disrupt residues predicted to facilitate GPI-anchoring, resulted in diminished surface expression of RAET1G. Thus, a form of RAET1G is GPI-anchored, in line with most other ULBP/RAET1 family proteins. The cytoplasmic tail and transmembrane domains appear to result from gene duplication and frameshift mutation. Together with our previous results, our data suggest that RAET1G is regulated post-translationally to produce a GPI-anchored isoform.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20304922      PMCID: PMC2878053          DOI: 10.1074/jbc.M109.077636

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium.

Authors:  V Groh; S Bahram; S Bauer; A Herman; M Beauchamp; T Spies
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

2.  The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor.

Authors:  Stephan Gasser; Sandra Orsulic; Eric J Brown; David H Raulet
Journal:  Nature       Date:  2005-07-03       Impact factor: 49.962

3.  Two subunits of glycosylphosphatidylinositol transamidase, GPI8 and PIG-T, form a functionally important intermolecular disulfide bridge.

Authors:  Kazuhito Ohishi; Kisaburo Nagamune; Yusuke Maeda; Taroh Kinoshita
Journal:  J Biol Chem       Date:  2003-02-11       Impact factor: 5.157

4.  BCR/ABL oncogene directly controls MHC class I chain-related molecule A expression in chronic myelogenous leukemia.

Authors:  Nicolas Boissel; Delphine Rea; Vannary Tieng; Nicolas Dulphy; Manuel Brun; Jean-Michel Cayuela; Philippe Rousselot; Ryad Tamouza; Philippe Le Bouteiller; François-Xavier Mahon; Alexander Steinle; Dominique Charron; Hervé Dombret; Antoine Toubert
Journal:  J Immunol       Date:  2006-04-15       Impact factor: 5.422

5.  Cutting edge: Toll-like receptor signaling in macrophages induces ligands for the NKG2D receptor.

Authors:  Jessica A Hamerman; Kouetsu Ogasawara; Lewis L Lanier
Journal:  J Immunol       Date:  2004-02-15       Impact factor: 5.422

6.  A second lineage of mammalian major histocompatibility complex class I genes.

Authors:  S Bahram; M Bresnahan; D E Geraghty; T Spies
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

7.  A new polymorphic and multicopy MHC gene family related to nonmammalian class I.

Authors:  C Leelayuwat; D C Townend; M A Degli-Esposti; L J Abraham; R L Dawkins
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

8.  Proteolytic release of soluble UL16-binding protein 2 from tumor cells.

Authors:  Inja Waldhauer; Alexander Steinle
Journal:  Cancer Res       Date:  2006-03-01       Impact factor: 12.701

9.  Two human ULBP/RAET1 molecules with transmembrane regions are ligands for NKG2D.

Authors:  Louise Bacon; Robert A Eagle; Martina Meyer; Nicholas Easom; Neil T Young; John Trowsdale
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

10.  Biosynthesis of glycosylphosphatidylinositol (GPI)-anchored membrane proteins in intact cells: specific amino acid requirements adjacent to the site of cleavage and GPI attachment.

Authors:  K Kodukula; L D Gerber; R Amthauer; L Brink; S Udenfriend
Journal:  J Cell Biol       Date:  1993-02       Impact factor: 10.539

View more
  8 in total

Review 1.  NKG2D Receptor and Its Ligands in Host Defense.

Authors:  Lewis L Lanier
Journal:  Cancer Immunol Res       Date:  2015-06       Impact factor: 11.151

Review 2.  Immunogenetics of the NKG2D ligand gene family.

Authors:  Masanori Kasahara; Shigeru Yoshida
Journal:  Immunogenetics       Date:  2012-07-29       Impact factor: 2.846

3.  Human NKG2D-ligands: cell biology strategies to ensure immune recognition.

Authors:  Lola Fernández-Messina; Hugh T Reyburn; Mar Valés-Gómez
Journal:  Front Immunol       Date:  2012-09-25       Impact factor: 7.561

4.  A Combined ULBP2 and SEMA5A Expression Signature as a Prognostic and Predictive Biomarker for Colon Cancer.

Authors:  Secil Demirkol; Ismail Gomceli; Murat Isbilen; Baris Emre Dayanc; Mesut Tez; Erdal Birol Bostanci; Nesrin Turhan; Musa Akoglu; Ezgi Ozyerli; Sevi Durdu; Ozlen Konu; Aviram Nissan; Mithat Gonen; Ali Osmay Gure
Journal:  J Cancer       Date:  2017-04-09       Impact factor: 4.207

Review 5.  Anti-NKG2D mAb: A New Treatment for Crohn's Disease?

Authors:  Kasper Vadstrup; Flemming Bendtsen
Journal:  Int J Mol Sci       Date:  2017-09-16       Impact factor: 5.923

Review 6.  Role of Polymorphisms of NKG2D Receptor and Its Ligands in Acute Myeloid Leukemia and Human Stem Cell Transplantation.

Authors:  Alena Machuldova; Monika Holubova; Valentina S Caputo; Miroslava Cedikova; Pavel Jindra; Lucie Houdova; Pavel Pitule
Journal:  Front Immunol       Date:  2021-03-30       Impact factor: 7.561

Review 7.  Leveraging NKG2D Ligands in Immuno-Oncology.

Authors:  Mercedes Beatriz Fuertes; Carolina Inés Domaica; Norberto Walter Zwirner
Journal:  Front Immunol       Date:  2021-07-29       Impact factor: 7.561

Review 8.  Glycosyl-Phosphatidyl-Inositol (GPI)-Anchors and Metalloproteases: Their Roles in the Regulation of Exosome Composition and NKG2D-Mediated Immune Recognition.

Authors:  Sheila López-Cobo; Carmen Campos-Silva; Mar Valés-Gómez
Journal:  Front Cell Dev Biol       Date:  2016-09-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.